ReviveMed is an AI-driven metabolomics platform for precision medicine, developed as an MIT spinout
ReviveMed is an AI-driven metabolomics platform for precision medicine, developed as an MIT spinout. The company focuses on creating digital metabolic twins to enhance drug response predictions and streamline clinical trials, particularly in oncology and cardio-metabolic diseases.